Dr. Adem AKÇAKAYA, Dr. Ramazan ERYILMAZ, Dr. Orhan ALİMOĞLU, Dr. Gürhan BAŞ, Dr. Mustafa ŞAHİN

SSK Vakıf Gureba Eğitim Hastanesi Cerrahi Kliniği / istanbul


Male breast cancer accounts for less than 1% of all breast cancers in men, and is more often diagnosed at a more advanced stage. The aim of this study was to present our clinical data of the patients with breast cancer in male. In this study, 10 males who were treated with diagnosis of breast cancer between January 1980 and May 2002, were analyzed retrospectively. The mean age was 59 years old (range, 39-76). Six tumors were localized in right breast and four in left breast. The preoperative pathological diagnosis was made by excisional biopsy in 3 cases, tru-cut biopsy in 3 cases, fine needle aspiration biopsy and frozen section in 3 cases, frozen section in 1 case. While one patient was treated with radical mastectomy, nine patients underwent modified radical mastectomy. The stages of patients were as follows; two patients (20%) in stage I, five stage (50%) IIa, two (20%) stage IIb, and one (10%) stage lllb. The histopathological diagnoses of all cases were invasive ductal carcinoma. Disease free median survival was 36 (range, 6-72) months. In conclusion; in most respects the clinical, histopathologic and prognostic factors of male breast cancer are similar to that of carcinoma of the breast in women, and treatment should be guided by similar principles. It appears that the prognosis for male patients with carcinoma of the breast is good if the appropriate treatment is undertaken at early stage

Keywords: Male, breast carcinoma, treatment